house · trading 2015-11-02 → 2024-11-21
*Purchases reported over roughly the last three years, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings state a range, never a share count, so this tracks the stock rather than the position. It is not a dollar figure and it is not what this member made.
By recent-buy return, Doug Lamborn ranks #17 of 118 lawmakers — better than 86% of Congress.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2024-11-21 | SPY | SELL | $1K–$15K | $593.67 | $770.19 2026-09-04 | -29.7% exit |
| 2024-11-21 | SPY | BUY | $1K–$15K | $593.67 | $770.19 2026-09-04 | +29.7% |
| 2024-11-21 | ITB | SELL | $1K–$15K | $118.45 | $89.87 2026-10-26 | +24.1% exit |
| 2024-10-04 | SPY | BUY | $1K–$15K | — | — | — |
| 2024-07-24 | NTAP | BUY | $1K–$15K | $125.70 | $207.08 2026-08-14 | +64.7% |
| 2024-07-24 | NTAP | SELL | $1K–$15K | $125.70 | $185.59 2026-09-04 | -47.6% exit |
| 2024-07-24 | NTAP | BUY | $1K–$15K | $125.70 | $185.59 2026-09-04 | +47.6% |
| 2024-07-22 | NTAP | BUY | $1K–$15K | $128.34 | $207.08 2026-08-14 | +61.4% |
| 2024-03-20 | NTAP | BUY | $15K–$50K | $104.44 | $185.59 2026-09-04 | +77.7% |
| 2024-03-20 | NTAP | BUY | $15K–$50K | $104.44 | $185.59 2026-09-04 | +77.7% |
| 2024-03-20 | NTAP | BUY | $15K–$50K | $104.44 | $185.59 2026-09-04 | +77.7% |
| 2024-03-01 | META | BUY | $1K–$15K | $502.30 | $630.56 2026-10-26 | +25.5% |
| 2023-12-06 | NTAP | SELL | $1K–$15K | $89.40 | $185.59 2026-09-04 | -107.6% exit |
| 2023-12-01 | NTAP | BUY | $1K–$15K | $91.28 | $185.59 2026-09-04 | +103.3% |
| 2023-07-07 | NTAP | BUY | $1K–$15K | $76.25 | $185.59 2026-09-04 | +143.4% |
| 2023-06-05 | NTAP | SELL | $1K–$15K | $70.28 | $207.08 2026-08-14 | -194.7% exit |
| 2023-06-05 | NTAP | SELL | $1K–$15K | $70.28 | $185.59 2026-09-04 | -164.1% exit |
| 2023-06-05 | NTAP | BUY | $50K–$50K | $70.28 | $185.59 2026-09-04 | +164.1% |
| 2023-06-05 | NTAP | BUY | $1K–$15K | $70.28 | $185.59 2026-09-04 | +164.1% |
| 2022-11-07 | NTAP | BUY | $1K–$15K | $69.39 | $207.08 2026-08-14 | +198.4% |
| 2022-08-29 | NTAP | BUY | $1K–$15K | $73.45 | $207.08 2026-08-14 | +181.9% |
| 2022-08-17 | NTAP | BUY | $1K–$15K | $73.37 | $207.08 2026-08-14 | +182.2% |
| 2022-08-15 | NTAP | BUY | $1K–$15K | $74.63 | $207.08 2026-08-14 | +177.5% |
| 2022-08-04 | NTAP | BUY | $1K–$15K | $72.11 | $207.08 2026-08-14 | +187.2% |
| 2022-07-25 | NTAP | BUY | $1K–$15K | $69.17 | $185.59 2026-09-04 | +168.3% |
| 2022-07-19 | NTAP | BUY | $1K–$15K | $68.31 | $185.59 2026-09-04 | +171.7% |
| 2022-07-18 | NTAP | BUY | $1K–$15K | $65.57 | $185.59 2026-09-04 | +183.0% |
| 2022-07-18 | META | BUY | $1K–$15K | $167.23 | $630.56 2026-10-26 | +277.1% |
| 2022-06-06 | NTAP | BUY | $1K–$15K | $70.87 | $207.08 2026-08-14 | +192.2% |
| 2021-11-09 | NTAP | SELL | $1K–$15K | $91.80 | $207.08 2026-08-14 | -125.6% exit |
| 2021-11-09 | NTAP | BUY | $1K–$15K | $91.80 | $207.08 2026-08-14 | +125.6% |
| 2021-11-08 | NTAP | SELL | $1K–$15K | $91.89 | $207.08 2026-08-14 | -125.4% exit |
| 2021-11-08 | NTAP | BUY | $1K–$15K | $91.89 | $207.08 2026-08-14 | +125.4% |
| 2021-10-26 | NTAP | BUY | $1K–$15K | $90.66 | $207.08 2026-08-14 | +128.4% |
| 2021-10-26 | NTAP | SELL | $1K–$15K | $90.66 | $185.59 2026-09-04 | -104.7% exit |
| 2021-10-26 | NTAP | BUY | $1K–$15K | $90.66 | $185.59 2026-09-04 | +104.7% |
| 2021-10-25 | NTAP | BUY | $1K–$15K | $93.10 | $207.08 2026-08-14 | +122.4% |
| 2021-10-25 | NTAP | BUY | $1K–$15K | $93.10 | $185.59 2026-09-04 | +99.3% |
| 2021-06-01 | SP | BUY | $1K–$15K | — | — | — |
| 2021-05-28 | SP | BUY | $1K–$15K | — | — | — |
| 2021-05-17 | SP | BUY | $1K–$15K | — | — | — |
| 2021-05-12 | SP | BUY | $1K–$15K | — | — | — |
| 2021-05-10 | NTAP | BUY | $1K–$15K | $78.86 | $207.08 2026-08-14 | +162.6% |
| 2021-04-26 | NTAP | BUY | $1K–$15K | $77.15 | $207.08 2026-08-14 | +168.4% |
| 2021-04-20 | NTAP | BUY | $1K–$15K | $75.19 | $207.08 2026-08-14 | +175.4% |
| 2021-03-19 | NTAP | BUY | $1K–$15K | $70.16 | $185.59 2026-09-04 | +164.5% |
| 2021-02-16 | NTAP | BUY | $1K–$15K | $68.85 | $185.59 2026-09-04 | +169.6% |
| 2021-02-08 | GSK | BUY | $1K–$15K | $35.46 | $51.10 2026-10-26 | +44.1% |
| 2020-12-30 | META | BUY | $1K–$15K | $271.87 | $630.56 2026-10-26 | +131.9% |
| 2020-12-28 | NET | BUY | $1K–$15K | $77.50 | $331.86 2026-10-26 | +328.2% |
Buys are marked to the latest close and treated as still open. A sell tagged rt closes an earlier disclosed buy in the same name. exit reads from the seller's side: how the stock moved after they were out.
| Member | Shared tickers |
|---|---|
| Rohit Khanna | 6 · NTAP, SP, NET, META, GSK, SPY |
| John Boozman | 4 · NTAP, META, GSK, SPY |
| Mike Kelly | 4 · SP, META, GSK, SPY |
| Josh Gottheimer | 3 · NET, META, SPY |
| Thomas R Carper | 3 · NTAP, GSK, SPY |
| Rob Bresnahan | 3 · NET, META, SPY |
| Michael T. McCaul | 2 · META, SPY |
| James B. Renacci | 2 · GSK, SPY |
| Thomas H Tuberville | 2 · META, GSK |
| Virginia Foxx | 2 · GSK, NAT |
| Gilbert Cisneros | 2 · NET, META |
| K. Michael Conaway | 2 · GSK, SPY |